Polaryx Therapeutics
$2.07
9
-$0.07-3.27% 19:31 Today
Statistics
Day High
2.14
Day Low
2.1
52W High
48.91
52W Low
1.85
Volume
8,738
Avg. Volume
91,514
Mkt Cap
103.18M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
2DecExpected
Q1 2026
Q2 2026
Next
-0.05
-0.04
-0.03
-0.02
Expected EPS
-0.0475
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-3.92MNet Income
Analyst Ratings
$6.67Average Price Target
The highest estimate is 7.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow PLYX. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Polaryx Therapeutics Inc is a clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric LSDs. Its therapeutic approach focuses on treating the underlying pathophysiology of these diseases and addressing unmet needs. The company's therapeutic pipeline includes PLX-200, PLX-300, and PLX-100, which are orally available small-molecule drug candidates designed to address core pathological mechanisms common to LSDs. The Company has one reportable segment: lysosomal storage disorders. The lysosomal storage disorders segment consists of the Company's costs associated with the preclinical and clinical development of the Company's product candidates.
Show more...
CEO
Alex Yang
Employees
11
Country
United States
ISIN
US73110F1003
Listings
0 Comments
Share your thoughts
FAQ
What is Polaryx Therapeutics stock price today?▼
The current price of PLYX is $2.07 USD — it has decreased by -3.27% in the past 24 hours. Watch Polaryx Therapeutics stock price performance more closely on the chart.
What is Polaryx Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Polaryx Therapeutics stocks are traded under the ticker PLYX.
What is Polaryx Therapeutics market cap?▼
Today Polaryx Therapeutics has the market capitalization of 103.18M
When is the next Polaryx Therapeutics earnings date?▼
Polaryx Therapeutics is going to release the next earnings report on December 02, 2026.
What were Polaryx Therapeutics earnings last quarter?▼
PLYX earnings for the last quarter are -0.03 USD per share, whereas the estimation was -0.04 USD resulting in a +14.29% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Polaryx Therapeutics revenue for the last year?▼
Polaryx Therapeutics revenue for the last year amounts to 0 USD.
What is Polaryx Therapeutics net income for the last year?▼
PLYX net income for the last year is -3.92M USD.
How many employees does Polaryx Therapeutics have?▼
As of September 25, 2026, the company has 11 employees.
In which sector is Polaryx Therapeutics located?▼
Polaryx Therapeutics operates in the Health & Wellness sector.
When did Polaryx Therapeutics complete a stock split?▼
Polaryx Therapeutics has not had any recent stock splits.
Where is Polaryx Therapeutics headquartered?▼
Polaryx Therapeutics is headquartered in PARAMUS, United States.